Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neurology

• Publication date

  2005-09-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000176753.45410.8bPMID 16186518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symptomatic Treatment of Multiple Sclerosis

  2006cited by this paper
• Symptoms and signs in patients with suspected neuropathic pain

  2004cited by this paper
• Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

  2004cited by this paper
• Pregabalin relieves symptoms of painful diabetic neuropathy

  2004cited by this paper
• CLASSIFICATION OF CHRONIC PAIN

  2004cited by this paper
• Can pain be more or less neuropathic?

  2004cited by this paper
• Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

  2003cited by this paper
• Tramadol in post‐herpetic neuralgia: a randomized, double‐blind, placebo‐controlled trial

  2003cited by this paper
• Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

  2003cited by this paper
• Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

  2003cited by this paper
• A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

  2003cited by this paper
• Safety, tolerability, and efficacy of orally administered cannabinoids in MS

  2002cited by this paper
• Cognitive functioning of long-term heavy cannabis users seeking treatment.

  2002cited by this paper
• Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

  2001cited by this paper
• Clinical importance of changes in chronic pain intensity measured on an 11‐point numerical pain rating scale

  2001cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• Textbook of Pain, 4th ed

  2001cited by this paper
• Worsening of symptoms of multiple sclerosis associated with carbamazepine

  2000cited by this paper
• Gabapentin for the Treatment of Postherpetic Neuralgia

  2000cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Anatomic correlates of painful tonic spasms in multiple sclerosis

  1999cited by this paper
• Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

  1999cited by this paper
• The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis

  1999cited by this paper
• Gabapentin for the Treatment of Postherpetic Neuralgia

  1999cited by this paper
• Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

  1998cited by this paper
• Symptomatic treatment in multiple sclerosis.

  1998cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Development and preliminary validation of a pain measure specific to neuropathic pain

  1997cited by this paper
• Open label gabapentin treatment for pain in multiple sclerosis

  1997cited by this paper
• Pain and central nervous system disease: The central pain syndromes

  1992cited by this paper
• Acute and chronic pain syndromes in multiple sclerosis

  1991cited by this paper
• Pain and central nervous system disease : the central pain syndromes

  1991cited by this paper
• Central pain.

  1990cited by this paper
• Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis ☆

  1989cited by this paper
• Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.

  1989cited by this paper
• The Hospital Anxiety and Depression Scale.

  1987cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• Paroxysmal attacks in multiple sclerosis.

  1975cited by this paper

• Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies

  2026influential citation
• Cannabis-Based Therapies for Chronic Orofacial Pain: A Systematic Review and Meta-Analysis

  2026cites this paper
• Cannabidiol attenuates methamphetamine-induced psychosis via anti-oxidative stress: σ1R-mediated mitochondrial dysfunction as a critical pathway.

  2026cites this paper
• Cannabis-based medicines for chronic neuropathic pain in adults.

  2026cites this paper
• Systematic review and network meta-analysis of the effects of bioactive compounds on pain intensity and quality of life in neuropathic pain patients

  2025cites this paper
• Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review

  2025cites this paper
• Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review

  2025cites this paper
• Treatments used by people living with MS to get to sleep or stay asleep, and impacts on sleep quality and daytime sleepiness.

  2025cites this paper
• A randomized trial on efficacy of purified cannabidiol on spasticity in multiple sclerosis patients with gait problems: first report in Iran

  2025cites this paper
• UK Medical Cannabis Registry: An Updated Analysis of Cannabis-Based Medicinal Products for Multiple Sclerosis

  2025cites this paper
• Interactions between cannabis use and chronic pain on sleep architecture: Findings from in-home EEG recordings.

  2025cites this paper
• Maintaining Mobility and Balance in Multiple Sclerosis: A Systematic Review Examining Potential Impact of Symptomatic Pharmacotherapy

  2025influential citation
• UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome

  2025cites this paper
• Cannabidiol as an immune modulator: A comprehensive review

  2025cites this paper
• Management of neuropathic pain and paresthesia in patients with multiple sclerosis: A systematic review and network meta-analysis.

  2025cites this paper
• Cannabis-Based Products for Chronic Pain : An Updated Systematic Review.

  2025cites this paper
• Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks

  2025influential citation
• The Effect of Medical Cannabis Laws on Use of Pain Medications Among Commercially Insured Patients in the United States

  2025cites this paper
• Are Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review

  2025influential citation
• Gabapentinoids for Neuropathic Pain After Spinal Cord Injury: An Updated Meta‐Analysis of Randomized Controlled Trials

  2025cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• Mirogabalin for Treatment of Neuropathic Pain and Associated Sleep Interference: An Updated Meta‐Analysis

  2025cites this paper
• Neuropathic pain in multiple sclerosis: serum biomarkers and MRI lesion localization

  2025cites this paper
• Unveiling Cannabinoids and Terpenes Diversity in Cannabis sativa L. From Northern India for Future Breeding Strategies

  2025cites this paper
• Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts

  2024cites this paper
• The Effect of E-Cigarette Taxes on Substance Use.

  2024cites this paper
• Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis

  2024cites this paper
• Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine

  2024cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Phytocannabinoids—Evaluation of their therapeutic role in neuroinflammation

  2024cites this paper
• Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease

  2024cites this paper
• Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review

  2024cites this paper
• Morpho-anatomical, phytochemical, and molecular diversity of North-Indian Cannabis sativa L. germplasms for CBD-rich genotypes

  2024cites this paper
• An overview on disease modifying and symptomatic drug treatments for multiple sclerosis

  2024cites this paper
• Medical cannabis: From research breakthroughs to shifting public perceptions and ensuring safe use

  2024cites this paper
• Efficiency of cannabis and cannabidiol in managing chronic pain syndromes: A comprehensive narrative review.

  2024cites this paper
• Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials

  2024cites this paper
• Evidence of Cannabidiol Effectiveness Associated or Not with Tetrahydrocannabinol in Topical Administration: A Scope Review

  2024influential citation
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England

  2024cites this paper
• Emerging Therapeutic Modalities and Pharmacotherapies in Neuropathic Pain Management: A Systematic Review and Meta-Analysis of Parallel Randomized Controlled Trials

  2024cites this paper
• Advising Around Cannabis for Sleep: Clearing Up the Smoke.

  2024cites this paper
• Cannabiskonsum und Cannabiskonsumstörungen

  2024cites this paper
• Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada – A Qualitative Study

  2023cites this paper
• Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review

  2023influential citation
• The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review

  2023influential citation
• A comprehensive review of the advances in neuromyelitis optica spectrum disorder.

  2023cites this paper
• CBD as a cure‐all? The impacts of state‐level legalization of prescription cannabidiol (CBD) on opioid prescriptions

  2023cites this paper
• A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

  2023cites this paper
• Cannabis and sleep disorders: not ready for prime time? A qualitative scoping review

  2023cites this paper
• Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

  2023cites this paper
• Cannabinoids in Symptomatic Treatment for People with Multiple Sclerosis: a Systematic Review of Randomised Studies

  2023cites this paper
• Neuropathic Pain in the Emergency Setting: Diagnosis and Management

  2023cites this paper
• Medicinal plants for the treatment of neuropathic pain: A review of randomized controlled trials.

  2023cites this paper
• Nociceptive and Mixed Pain Syndromes in Patients with Multiple Sclerosis

  2023cites this paper
• Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

  2023influential citation
• Neuroinflammation in the Pathogenesis of Neuropathic Pain Syndrome

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Can we predict the treatment doses of THC and CBD and does it matter?

  2023cites this paper
• Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 2

  2023cites this paper
• Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

  2023cites this paper
• Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 3

  2023influential citation
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic

  2023influential citation
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 4

  2023influential citation
• Cannabis products: medical use

  2023cites this paper
• Dorsal Column Stimulation and Cannabinoids in the Treatment of Chronic Nociceptive and Neuropathic Pain: a Review of the Clinical and Pre-clinical Data

  2022cites this paper
• Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

  2022cites this paper
• Pathogenesis and management of multiple sclerosis revisited.

  2022cites this paper
• Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

  2022cites this paper
• Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006-2018.

  2022cites this paper
• Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 4

  2022cites this paper
• A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021

  2022cites this paper
• The effect of medical cannabis on cognitive functions: a systematic review

  2022cites this paper
• Effects of Sativex® on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.

  2022cites this paper
• Management of central neuropathic pain involves many drugs but few have proven efficacy

  2022cites this paper
• Cannabidiol Promotes Adipogenesis of Human and Mouse Mesenchymal Stem Cells via PPARγ by Inducing Lipogenesis but Not Lipolysis.

  2022cites this paper
• Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3

  2022cites this paper
• Use of Cannabidiol in the Management of Insomnia: A Systematic Review

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2

  2022cites this paper
• Neuropathic Pain in Multiple Sclerosis Patients

  2022cites this paper
• [Nociceptive and mixed pains in patients with multiple sclerosis].

  2022cites this paper
• The Management of Poststroke Thalamic Pain: Update in Clinical Practice

  2022cites this paper
• [Neuroinflammation in the pathogenesis of central neuropathic pain].

  2022cites this paper
• Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis

  2022cites this paper
• Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

  2022cites this paper
• Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition

  2022cites this paper
• Efficacy of cannabis and its constituents in disease management: Insights from clinical studies.

  2022cites this paper
• Cannabidiol in the Treatment of Mood Disorders

  2022cites this paper
• Individual Approach in Achieving Optimal Balance of THC and CBD in Supplementary Treatment of Neurological Diseases

  2022cites this paper
• Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry

  2022cites this paper
• The effects of recreational marijuana legalization on employment and earnings

  2022cites this paper
• Cannabis-Based Products for Chronic Pain

  2022influential citation
• The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms

  2022cites this paper
• Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 1, September 2022

  2022cites this paper
• Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain

  2022cites this paper
• A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis

  2022cites this paper